Methods and compositions for immunoregulation

Details for Australian Patent Application No. 2001242159 (hide)

Owner Trillium Therapeutics Inc.

Inventors Gorczynski, Reginald M.; Clark, David A

Agent Davies Collison Cave

Pub. Number AU-B-2001242159

PCT Pub. Number WO01/68697

Priority 60189986 17.03.00 US

Filing date 16 March 2001

Wipo publication date 24 September 2001

Acceptance publication date 27 April 2006

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 November 2003 Assignment before Grant

  Clark, David; Gorczynski, Reginald The application has been assigned to Transplantation Technologies Inc.

27 April 2006 Application Accepted

  Published as AU-B-2001242159

27 April 2006 Change of Name(s) of Applicant(s), Section 104

  Transplantation Technologies Inc. The name of the applicant has been changed to Trillium Therapeutics Inc. Change of Name(s) of Applicant(s), Section 104

24 August 2006 Standard Patent Sealed

13 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001242161-Dynamic heating and cooling of a building using liquid foam

2001242158-Benzylated pde4 inhibitors